Clinic Software← All companies
Pantheon Vision
Pantheon Vision: Eliminating corneal blindness
healthcare AI/biotech/medtech (corneal blindnessocular bioengineering)
Stageseed
Raised$4.3 million
Founded2023
Employees3
LocationBaltimore, MD
About
Pantheon Vision is an early stage medical device company developing bioengineered solutions to reduce the reliance on donor tissue to address corneal blindness.
Product
- Value proposition
- Developing bioengineered solutions to reduce reliance on donor tissue and address corneal blindness, enabling scalable, accessible vision restoration worldwide.
Founders
- John Sheets — CEO/President
Products
bioengineered solutions for corneal blindness
Key features
bioengineered corneal solutions to reduce donor tissue relianceaims for safe, effective, accessible and scalable procedures
Technologies
bioengineered tissuetissue processingsight restoration
Target conditions
corneal blindnesscorneal transplant-improve alternatives
Investors
KeraLink International
News
- Pantheon Vision Signs Collaboration Agreement with Eyedeal Medical to Develop Bioengineered Corneal Implant · 2025-03-27T00:00:00.000Z
- Q&A: Pantheon Vision developing alternative to donor tissue for corneal transplants · 2025-01-14T19:50:45.000Z
- Pantheon Vision reports positive pre-clinical FDA meeting on bioengineered corneal implants · 2025-02-03T08:22:13.000Z
- Pantheon Vision taps Eyedeal Medical for corneal implant manufacturing - Medical Device Network · 2025-03-28T11:04:15.000Z
- Pantheon Vision Reflects on a Year of Milestones and Sets Bold Goals for 2025 · 2025-02-13T13:00:00.000Z
- Pantheon Vision and Eyedeal Medical enter collaborative agreement to develop bioengineered corneal implant · 2025-03-28T10:00:00.000Z
